Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life Science, bringing extensive experience in the pharmaceutical industry, healthcare consulting and commercial strategy to the role. Suzuki has…
Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…
Zero System Co., Ltd. has developed a new system that integrates its…
Flora Inc., which develops healthcare services utilizing technology and data with a…
MRSO Co., Ltd. has launched MRSO Security, a service designed to help…
Neumarker and Cortica have formed a partnership to explore how artificial intelligence…
What amount of patient information can a physician process before any clinical…
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…
Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…
Ken Suzuki has joined Accenture as Principle Director, Industry and Enterprise, Life…
Zero System Co., Ltd. has developed a new system that integrates its…
Flora Inc., which develops healthcare services utilizing technology and data with a…
MRSO Co., Ltd. has launched MRSO Security, a service designed to help…
Neumarker and Cortica have formed a partnership to explore how artificial intelligence…
What amount of patient information can a physician process before any clinical…
Rhythm Pharmaceuticals is now selling IM CIVREE in Japan. The drug contains…
Zealand Pharma and Generate Biomedicines have entered a collaboration to develop AI‑engineered…
Sign in to your account